UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-resistant disease

Authors

Michael J Birrer, MD, PhD

Professor of Medicine

Harvard Medical School

Keiichi Fujiwara, MD, PhD

Professor of Gynecologic Oncology

Saitama Medical University

Section Editors

Barbara Goff, MD

Section Editor — Gynecologic Oncology

Department Chair, Gynecologic Oncology

Surgeon-in-Chief

University of Washington Medical Center

Don S Dizon, MD, FACP

Section Editor – Gynecologic Oncology

Head of Women's Cancers, Lifespan Cancer Institute

Director of Medical Oncology, Rhode Island Hospital

Associate Professor of Medicine, Warren Alpert Medical School of Brown University

Deputy Editor

Sadhna R Vora, MD

Deputy Editor — Oncology

Instructor in Medicine

Harvard Medical School

Peer Reviewer

Reviewers are not identified on topic reviews to preserve anonymity